Systemic implementation strategies to improve hypertension: The Kaiser permanente southern california experience

Canadian Journal of Cardiology

Volumn 30, Issue 5, 2014, Pages 544-552

  Sim, John J ^a   Handler, Joel ^b   Jacobsen, Steven J ^c   Kanter, Michael H ^b  

^a KAISER PERMANENTE MEDICAL CENTER   (United States)

^b KAISER PERMANENTE   (United States)

^c Department of Research and Evaluation Kaiser Permanente Southern California ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE; ATENOLOL; CHLORTALIDONE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROCHLOROTHIAZIDE; HYDROCHLOROTHIAZIDE PLUS LISINOPRIL; LISINOPRIL; SPIRONOLACTONE;

ALGORITHM; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; ELECTRONIC MEDICAL RECORD; EVIDENCE BASED PRACTICE; HEALTH CARE PERSONNEL; HUMAN; HYPERTENSION; INTEGRATED HEALTH CARE SYSTEM; MEDICAL ASSISTANT; NURSE; PHARMACIST; PHYSICIAN; PRACTICE GUIDELINE; REGISTER; RESISTANT HYPERTENSION; REVIEW; UNITED STATES;

CALIFORNIA; DELIVERY OF HEALTH CARE; DIAGNOSTIC TECHNIQUES, CARDIOVASCULAR; DISEASE MANAGEMENT; HUMANS; HYPERTENSION; MANAGED CARE PROGRAMS; MORBIDITY; PRACTICE GUIDELINES AS TOPIC; REGISTRIES;

EID: 84899630739     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cjca.2014.01.003     Document Type: Review

References (56)

1. Egan B.M., Zhao Y., Axon R.N. US trends in prevalence, awareness, treatment, and control of hypertension, 1988-2008. JAMA 2010, 303:2043-2050.
2. Cherry D.K., Hing E., Woodwell D.A., Rechtsteiner E.A. National Ambulatory Medical Care Survey: 2006 summary. Natl Health Stat Report 2008, 1-39.
3. Wolf-Maier K., Cooper R.S., Banegas J.R., et al. Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States. JAMA 2003, 289:2363-2369.
4. Effects of treatment on morbidity in hypertension. Results in patients with diastolic blood pressures averaging 115 through 129 mm Hg. JAMA 1967, 202:1028-1034.
5. Klag M.J., Whelton P.K., Randall B.L., et al. Blood pressure and end-stage renal disease in men. N Engl J Med 1996, 334:13-18.
6. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group. JAMA 1991, 265:3255-3264.
7. Turnbull F., Neal B., Ninomiya T., et al. Effects of different regimens to lower blood pressure on major cardiovascular events in older and younger adults: meta-analysis of randomised trials. BMJ 2008, 336:1121-1123.
8. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group. BMJ 1998, 317:703-713.
9. Hansson L., Zanchetti A., Carruthers S.G., et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group. Lancet 1998, 351:1755-1762.
10. McAlister F.A., Robitaille C., Gillespie C., et al. The impact of cardiovascular risk-factor profiles on blood pressure control rates in adults from Canada and the United States. Can J Cardiol 2013, 29:598-605.
11. Sarafidis P.A., Bakris G.L. State of hypertension management in the United States: confluence of risk factors and the prevalence of resistant hypertension. J Clin Hypertens (Greenwich) 2008, 10:130-139.
12. Persell S.D. Prevalence of resistant hypertension in the United States, 2003-2008. Hypertension 2011, 57:1076-1080.
13. Egan B.M., Zhao Y., Axon R.N., Brzezinski W.A., Ferdinand K.C. Uncontrolled and apparent treatment resistant hypertension in the United States, 1988 to 2008. Circulation 2011, 124:1046-1058.
14. Roger V.L., Go A.S., Lloyd-Jones D.M., et al. Heart disease and stroke statistics-2012 update: a report from the American Heart Association. Circulation 2012, 125:e2-220.
15. Heidenreich P.A., Trogdon J.G., Khavjou O.A., et al. Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association. Circulation 2011, 123:933-944.
16. Wagner E.H., Austin B.T., Von Korff M. Organizing care for patients with chronic illness. Milbank Q 1996, 74:511-544.
17. Wagner E.H., Warner J.T., Slome C. Medical care use and hypertension. Med Care 1980, 18:1241-1250.
18. Kaczorowski J., Del Grande C., Nadeau-Grenier V. Community-based programs to improve prevention and management of hypertension: recent Canadian experiences, challenges, and opportunities. Can J Cardiol 2013, 29:571-578.
19. Tobe S.W., Moy Lum-Kwong M., Von Sychowski S., Kandukur K. Hypertension management initiative: qualitative results from implementing clinical practice guidelines in primary care through a facilitated practice program. Can J Cardiol 2013, 29:632-635.
20. Nelson S.A., Dresser G.K., Vandervoort M.K., et al. Barriers to blood pressure control: a STITCH substudy. J Clin Hypertens (Greenwich) 2011, 13:73-80.
21. Alexander M., Gordon N.P., Davis C.C., Chen R.S. Patient knowledge and awareness of hypertension is suboptimal: results from a large health maintenance organization. J Clin Hypertens (Greenwich) 2003, 5:254-260.
22. Egan B.M., Lackland D.T., Cutler N.E. Awareness, knowledge, and attitudes of older Americans about high blood pressure: implications for health care policy, education, and research. Arch Int Med 2003, 163:681-687.
23. Williams M.V., Baker D.W., Parker R.M., Nurss J.R. Relationship of functional health literacy to patients' knowledge of their chronic disease. A study of patients with hypertension and diabetes. Arch Int Med 1998, 158:166-172.
24. Jaffe M.G., Lee G.A., Young J.D., Sidney S., Go A.S. Improved blood pressure control associated with a large-scale hypertension program. JAMA 2013, 310:699-705.
25. Yeh R.W., Sidney S., Chandra M., et al. Population trends in the incidence and outcomes of acute myocardial infarction. N Engl J Med 2010, 362:2155-2165.
26. Koebnick C., Langer-Gould A.M., Gould M.K., et al. Sociodemographic characteristics of members of a large, integrated health care system: comparison with US Census Bureau data. Perm J 2012, 16:37-41.
27. Sim J.J., Bhandari S.K., Shi J., et al. Characteristics of resistant hypertension in a large, ethnically diverse hypertension population of an integrated health system. Mayo Clin Proc 2013, 88:1099-1107.
28. Kanter M.H., Lindsay G., Bellows J., Chase A. Complete Care at Kaiser Permanente: transforming chronic and preventive care. Jt Comm J Qual Patient Saf 2013, 39:484-494.
29. Selby J.V., Lee J., Swain B.E., et al. Trends in time to confirmation and recognition of new-onset hypertension, 2002-2006. Hypertension 2010, 56:605-611.
30. Chapman J.A., Johnson J.A. On the spot! Peer validation of BP measurement competence. Nurs Manage 2013, 44:22-24.
31. Ringerman E., Flint L.L., Hughes D.E. An innovative education program: the peer competency validator model. J Nurses Staff Dev 2006, 22:114-121. [quiz 22-3].
32. Handler J., Zhao Y., Egan B.M. Impact of the number of blood pressure measurements on blood pressure classification in US adults: NHANES 1999-2008. J Clin Hypertens (Greenwich) 2012, 14:751-759.
33. Feldman R.D., Zou G.Y., Vandervoort M.K., et al. A simplified approach to the treatment of uncomplicated hypertension: a cluster randomized, controlled trial. Hypertension 2009, 53:646-653.
34. Byrd J.B., Zeng C., Tavel H.M., et al. Combination therapy as initial treatment for newly diagnosed hypertension. Am Heart J 2011, 162:340-346.
35. Cushman W.C., Ford C.E., Cutler J.A., et al. Success and predictors of blood pressure control in diverse North American settings: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). J Clin Hypertens (Greenwich) 2002, 4:393-404.
36. Sim J.J., Bhandari S.K., Shi J., et al. Plasma renin activity (PRA) levels and antihypertensive drug use in a large healthcare system. Am J Hypertens 2011, 25:379-388.
37. Fung V., Huang J., Brand R., Newhouse J.P., Hsu J. Hypertension treatment in a medicare population: adherence and systolic blood pressure control. Clin Ther 2007, 29:972-984.
38. Harrison T.N., Ho T.S., Handler J., et al. A randomized controlled trial of an automated telephone intervention to improve blood pressure control. J Clin Hypertens (Greenwich) 2013, 15:650-654.
39. Kanter M., Martinez O., Lindsay G., Andrews K., Denver C. Proactive office encounter: a systematic approach to preventive and chronic care at every patient encounter. Perm J 2010, 14:38-43.
40. Yiannakopoulou E., Papadopulos J.S., Cokkinos D.V., Mountokalakis T.D. Adherence to antihypertensive treatment: a critical factor for blood pressure control. Eur J Cardiovasc Prev Rehabil 2005, 12:243-249.
41. Bramley T.J., Gerbino P.P., Nightengale B.S., Frech-Tamas F. Relationship of blood pressure control to adherence with antihypertensive monotherapy in 13 managed care organizations. J Manag Care Pharm 2006, 12:239-245.
42. Garg J.P., Elliott W.J., Folker A., Izhar M., Black H.R. Resistant hypertension revisited: a comparison of two university-based cohorts. Am J Hypertens 2005, 18:619-626.
43. Ho P.M., Bryson C.L., Rumsfeld J.S. Medication adherence: its importance in cardiovascular outcomes. Circulation 2009, 119:3028-3035.
44. Ho P.M., Rumsfeld J.S., Masoudi F.A., et al. Effect of medication nonadherence on hospitalization and mortality among patients with diabetes mellitus. Arch Int Med 2006, 166:1836-1841.
45. Van Wijk B.L., Klungel O.H., Heerdink E.R., de Boer A. Rate and determinants of 10-year persistence with antihypertensive drugs. J Hypertens 2005, 23:2101-2107.
46. Mazzaglia G., Mantovani L.G., Sturkenboom M.C., et al. Patterns of persistence with antihypertensive medications in newly diagnosed hypertensive patients in Italy: a retrospective cohort study in primary care. J Hypertens 2005, 23:2093-2100.
47. Vrijens B., Vincze G., Kristanto P., Urquhart J., Burnier M. Adherence to prescribed antihypertensive drug treatments: longitudinal study of electronically compiled dosing histories. BMJ 2008, 336:1114-1117.
48. Bosworth H.B., Olsen M.K., Goldstein M.K., et al. The veterans' study to improve the control of hypertension (V-STITCH): design and methodology. Contemp Clin Trials 2005, 26:155-168.
49. Roumie C.L., Elasy T.A., Greevy R., et al. Improving blood pressure control through provider education, provider alerts, and patient education: a cluster randomized trial. Ann Int Med 2006, 145:165-175.
50. Kovesdy C.P., Bleyer A.J., Molnar M.Z., et al. Blood pressure and mortality in U.S. Veterans with chronic kidney disease: a cohort study. Ann Int Med 2013, 159:233-242.
51. Alderman M.H., Cohen H.W., Sealey J.E., Laragh J.H. Plasma renin activity levels in hypertensive persons: their wide range and lack of suppression in diabetic and in most elderly patients. Am J Hypertens 2004, 17:1-7.
52. Handler J., Lackland D.T. Translation of hypertension treatment guidelines into practice: a review of implementation. J Am Soc Hypertens 2011, 5:197-207.
53. Fletcher R.D., Amdur R.L., Kolodner R., et al. Blood pressure control among US veterans: a large multiyear analysis of blood pressure data from the Veterans Administration health data repository. Circulation 2012, 125:2462-2468.
54. U.S. Department of Veterans Affairs. Quality of Care. Available at: Accessed December 3, 2013. http://www.va.gov/QUALITYOFCARE/initiatives/compare/high-blood-pressure-control.asp.
55. Bex S.D., Boldt A.S., Needham S.B., et al. Effectiveness of a hypertension care management program provided by clinical pharmacists for veterans. Pharmacotherapy 2011, 31:31-38.
56. Zhou Y.Y., Kanter M.H., Wang J.J., Garrido T. Improved quality at Kaiser Permanente through e-mail between physicians and patients. Health Aff (Millwood) 2010, 29:1370-1375.